Item 2.02 Results of Operations and Financial Condition.
On
Item 7.01 Regulation FD Disclosure.
On
The information in this Current Report on Form 8-K (including Exhibits 99.1 and 99.2) shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description 99.1 Press release announcing the Company's financial results for the second quarter endedJune 30, 2021 , datedAugust 9, 2021 . 99.2 Press release announcing the Company's collaboration withYale University's Department of Immunobiology 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
--------------------------------------------------------------------------------
© Edgar Online, source